Skip to main content

ORTHOFIX International N V Value Stock - Dividend - Research Selection

ORTHOFIX International N V

ISIN: US68752M1080, WKN: A2NB0X

Market price date: 26.05.2021
Market price: 40,84 USD

ORTHOFIX International N V Fundamental data and company key figures of the share

Annual reports in USD
Key figures 02-03-2021
Cash flow
Net operating cash flow 74.272.000
Capital Expenditures -15.485.000
Free cash flow 58.787.000
Balance sheet
Total Equity 356.864.000
Liabilities & Shareholders equity 525.861.000
Income statement
Net income 2.517.000
Eps (diluted) 0,130
Diluted shares outstanding 19.423.900
Net sales/revenue 406.562.000

Fundamental ratios calculated on: 26-05-2021

Key figures 26-05-2021
Cash flow
P/C 10,68
P/FC 13,49
Balance sheet
Income statement
Div. Yield0,00%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization793.272.064,00 USD
IndicesNASDAQ Comp.
Raw Data SourceUS GAAP in Millionen USD
Stock Split

Description of the company

Orthofix International N.V. (Orthofix) is a diversified, global medical device company focused on developing and delivering repair and regenerative solutions to the spine and orthopedic markets. The Company operates in two global business units, which include Spine and Orthopedics. It designs, develops, manufactures, markets and distributes medical equipment used principally by musculoskeletal medical specialists for spine and orthopedic applications. Its main products are spinal implant products and related human cellular and tissue based products (HCT/P products) used in surgical procedures, non-invasive regenerative stimulation products used to enhance bone growth and the success rate of spinal fusions and to treat non-union fractures, external and internal fixation devices used in fracture repair, limb lengthening and bone reconstruction.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,